chrisvoncsefalvay/vaers-outcomes huggingface dataset:
S/P redness and swelling of (L) thigh 3 inches by 3.5 inches today - resolving was larger per patient.
Heat at injection site; Redness at injection site; Injection arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Injection arm soreness), VACCINATION SITE WARMTH (Heat at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Injection arm soreness). On 28-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heat at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Feb-2021, PAIN IN EXTREMITY (Injection arm soreness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Heat at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant provided
Redness in skin, Arm hard to lift with sharp pain with movement and touch, skin irritation, skin hot, redness of skin 8 inchs in length, 4 inches width on arm.
After I had the Moderna vaccine shot, my heart started racing for the first 5 to 6 minutes. I tried to calm myself down to stop it. I continued to sit for my remaining 15 minutes and left. Other than soreness at the injection site for about 3 days, there was no other side effects.
This spontaneous report was received from a registered nurse referring to an 8 week old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. In approximately September 2017, reported as "24-SEP-2017", (conflicting information because the patient was reported had been born on 27-SEP-2017), 25-OCT-2017 and 28-NOV-2017, the patient was administered the first, second and third doses, respectively, of RECOMBIVAX HB, for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse effects were reported.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC RESPIRATORY FAILURE 2/10/2023 &  1/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Fever for 3 days muscle soreness for 5 days Joint pain for 6 days Hives and Swollen hands 4 weeks
Patient developed significant facial urticaria which progressed to involved his lips and swelling of the tip of his tongue (at which point he was sent to the emergency department).
p/vax pt devel persistent crying in office-consolable & for 2 hr @ home;irritable 6/19/99 & 6/20/99;to local ER reported bleeding gums & ulcers @ tip of tongue 6/20/99;afeb placed on APAP & amox;irritability improved & ulcer on outer lip
At the vaccine site on my left arm developed a red large area (about6 inches in diameter) and was occasionally itchy.  Today, 2 days later, the redness is fading and is still itching on occasion.  Symptoms are mild and tolerable, but thought the data should be recorded.
So I have been through menopause for 15 years, and i woke up on Friday and was on my period. it was very light but it lasted for 7 days. Well then I started having hot flashes again which is the reason I called my Dr. because I was bleeding and the hot flashes.  he stated that it was just a reaction to the shot and he increased my Progestrone tp help with the hot flashes. My hormones were a little bit out off balance but after proper testing, it was not off enough for me to change my medications.
first dose of Shingrix on 2019/ second dose today (July 2021).; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in unknown date in 2019).   In July 2021, the patient received the 2nd dose of Shingrix. In July 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional case details were reported as follows: Pharmacist reported that a patient came back to the facility to receive the 2nd dose on the day of reporting (July 2021) that was later than recommended schedule which led to lengthening of vaccination schedule. As per conservative approach as the patient come back the facility for 2nd dose of vaccination she must had received. Lot number and expiration date was not available. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.
5:02p - reaction time;  Blood sugar - 169;  O2=94; HR 57; BP 110/68; Pt complains dizziness, sweats, no SOB
Ideopathic Immunothrombocytopenic Purpura (ITP) - Bloody Nose, Bleeding Gums, Bruising, Petechiae, Platelet Count of 2000. Given IV fluids, steroids through IV and orally. Continual bloodwork monitoring platelet count. Hospitalization for 5 days.
Body rash; Headache; Pain at the injection site; A spontaneous report was received from a consumer concerning a 57-year-old, male patient who experienced a headache, pain at the injection site and a body rash.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 26-Dec-2020, approximately one day prior to the onset of the symptoms, the patient received the first of two planned doses of mRNA-1273 (Lot 037K20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.   On 27-Dec-2020, the patient experienced a headache and pain at the injection site. On 30-Dec-2020, he developed a body rash that has persisted to date (at the time of the report).The patient took  Benadryl (diphenhydramine), but there was no improvement.    Action taken with mRNA-1273 in response to the event was unknown.   The event, body rash was not resolved. The outcomes of the events headache and pain at injection site, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever, chills, shaking, light headed, headache, no appetite, slight nausea. Fever started around 8-9 pm the day of the shot, then fever went up to 102 overnight, then back down to 99.7 through most of the next day. Shaking didn't last long but had chills off & on through the 1st night. Light headedness, headache, slight nausea and no appetite lasted all the 2nd day and I was very tired. Slight headache the 3rd day but cleared up and no other symptoms that day.
pt c/o nausea, lightheadedness p/vax; color pale & not site irritation noted; no rash; no resp distress; pt did not lose consciousness; observation only;
1 hour after vaccine ---EXTREME HEART PALPATATIONS--FELT I WOULD PASS OUT WHEN I STOOD UP---LASTER APPROX 20 MIN.----THEN 1 HOUR LATER MORE EXTREME HEART PALPATATIONS AGAIN.
Red rashes/welts appearing and disappearing on random parts of body below neck.  Treating with calamine lotion to treat itching. I have no known allergies. I am going to see if my primary can refer me to a specialist.
This case was reported by a nurse via sales rep and described the occurrence of pain in an unspecified number of patients who received BEXSERO. On an unknown date, the patient received BEXSERO. On an unknown date, unknown after receiving BEXSERO, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not applicable for this report. The health care professional reported that the patients have experienced pain after receiving BEXSERO. No additional patient or product information was provided.
Hep A vaccine given on 7/17/02. Within hours developed hives. Hives waxed and waned. Rx with Zynec/Benadryl. Progressed to serum sickness-fever, it swelling and hives 8/6/02.
Dose 3 received; Swelling of throat; swelling of tongue; Swelling of eyes; This is a spontaneous report from a contactable consumer. A 39-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Oct2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 18Oct2021, the patient experienced swelling of throat, tongue and eyes. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included unspecified treatment. The clinical outcome of the events swelling of throat, tongue and eyes was unknown at the time of this report. The event occurred in a country different from that of the reporter. This may be a duplicate report if another reporter from the country where the event occurred has submitted the same information to his/her local agency.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No other AE; Received a dose of MMRII that was reconstituted with normal saline; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications and drug reaction/allergies were not reported.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (dose, lot number, expiration date, anatomical site of administration, and route of administration were not provided) as prophylaxis, which was reconstituted with normal sodium chloride (SALINEX) (strength, dose, formulation, dose description, lot number, expiration date, route of administration, and indication were not provided) (Product preparation issue). No other adverse event (AE) (no AE).  This case is non-valid due to lack of patient's identifiers.  Follow-up information has been received from the pharmacist on 22-MAR-2023.  The patient was a 40-year-old male.  On 03-MAR-2023, he was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously at the left (unspecified) (Lot Number W032499 with expiration date reported as 22-NOV-2023 is NOT valid for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [M-M-R II]), however the vaccine was reconstituted with the wrong diluent, as it was used normal sodium chloride (INNO.N 0.9% SODIUM CHLORIDE) instead of diluent (Product preparation error). The patient was fine and no complications or reactions were reported.
I had only slight soreness at the site of the injection on the day of injection. However, I woke up the next morning with sharp heel pain in my right heel. Symptoms were like classic plantar fascitis, but it went away after about 3 days. Now seems normal.
Approx 10 hrs after injection severe left arm pain, progressed to all over body aches about 12 hrs post vaccination. Approx 24-30 hrs post vaccination chills and slight headache added and remained until approx 48 hours post. Took Motrin for aches and rested with restricted movement
Patient past out after getting shot. Recovered within 1 minute.  BP 100/60, Pulse ox 98, pulse 68.  Evaluated for 30 minutes.
received first dose on 2019, never got 2nd dose; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 30th December 2019, batch number JNKR, expiry date 29th November 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The health care professional reported that, the patient received first dose of Shingrix and never had 2nd dose, which led to incomplete course of vaccination. The reporter consented to follow up. This is one of the two cases, reported by the same reporter.
Patient stated had spots on right deltoid 6 days after Tdap. He put hydrocortisone cream on it because it was slightly itchy. Two days later it developed erythema. It was not warm to the touch. Patient reports feeling normal otherwise.
Patient is stating that she still has arm pain and hardness at the injection site 7 months after the Shingrix injection. We recommended that patient uses lidocaine cream and/or diclofenac gel over the counter. If problem continues, patient should contact her primary care provider.
Reported rash on back continues since bad hives during allergic reaction to DTAP/HIB. Rash worse with heat gets redder around perimeter.
Heavy-headededness Sleepiness Difficulty with uprightness  Eyes seeing fogginess Unbearable grogginess
Patient noted some throat swelling a couple minutes after vaccine. Epi and benadryl given. patient refused 911 transport. Monitored in tent and discharged in care of accompanying party in stable conditions. Precautions and reaction advise given.
doesn't feel right leg or left arm; cramps in her stomach; Shaking; Sweating; throwing up; feeling really sick; This is a spontaneous report from a contactable consumer (patients sister). A 14-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number, expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 01Jun2021 at like around 12:30 or 1:00 pm (as reported) as single dose for covid-19 immunisation. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. No additional vaccines were administered on the same date of COVID-19 vaccine. The patient medical history and concomitant medications were not reported. Family medical history relevant to AEs was none. Patient was not taking any other products. Patient did not had prior vaccination within 4 weeks. On 02Jun2021 reporter stated that her 14 year old sister got vaccinated yesterday and when she woke up she felt really sick. On 02Jun2021, at 09:00 the patient experienced cramps in her stomach, shaking, sweating, throwing up and has gotten worse. On 02Jun2021, patient reported she felt like she did not feel one of her legs and one of her arms. Clarified that it is the right leg and the left arm. Started about an hour and a half later than the other symptoms, so was around 10:30 this morning and had gotten worse. Patient did not visit emergency room or physician office. No treatment was received for the events cramps in her stomach, shaking, sweating, throwing up, felt like she did not feel one of her legs and one of her arms. When they passed through the place to get the vaccine, they said to get it just in case, for the next school year. Investigation assessment and relevant tests was reported as no. The outcome of events cramps in her stomach, shaking, sweating, throwing up, doesn't feel right leg or left arm was not recovered and the outcome of other event was unknown.    Information related to batch/Lot no. was requested.
soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (soreness) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     The patient's past medical history included Graves' disease. Concomitant products included THIAMAZOLE (METHIMAZOLE) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, Blood thyroid stimulating hormone: 2.51 normal. In January 2021, Thyroxine: 1.37. On 12-May-2021, Blood thyroid stimulating hormone: 0.075 (Low) Patient said numbers were off and numbers were perfect last year and in January. On 12-May-2021, Thyroxine: 1.79 Patient reported numbers were off.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported to have done T3, T4 and TSH tests (since he was reported to have Graves' disease in the past medical history) on 12-MAY-2021 and reported that the numbers were off which were perfect last year and in January.   Patient also reported that the medication regimen had not been changed and the only difference was getting the vaccine.   No treatment medications were reported.
Face numbness, numbness in roof of mouth, loss of taste, thick saliva now lasting over 6 months
Injection site soreness; enlarged, painful lymph nodes in left arm pit; enlarged, painful lymph nodes in left arm pit; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received second dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine, lot number EM9810), via an unspecified route of administration at Arm Left on 04Feb2021 17:00 at the 33 years old at single dose for COVID-19 immunization.  The medical history was none. The Known allergies was None. The concomitant medication was hydrochlorothiazide, lisinopril (LISINOPRIL/HCTZ). The Historical Vaccine was first dose BNT162B2(lot number EL3249) on 15Jan2021 07:00 at 33-year-old at Left arm for COVID-19 immunization. The patient experienced Injection site soreness and enlarged, painful lymph nodes in left arm pit on 06Feb2021 05:00. The event Injection site soreness was resolving after 36 hours. There was no other vaccine in four weeks. There was not treatment received for all the events. The patient had no Covid prior vaccination. There was no Covid tested post vaccination. The outcome of the event Injection site soreness was recovering, the other events was unknown.
Patient had immediate pain upon administration of vaccine.  She described having an an electrical shock down her arm, as well as severe pain involving her shoulder.  Following the vaccination, she developed reduced range of motion of the shoulder, subjective weakness, and severe pain with lifting overhead and lying on arm.  She has been seen by orthopedic specialist in physical therapy providers, with concern for rotator cuff injury.  She is getting an MRI to rule out rotator cuff tear..
Feeling sick; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling sick in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25-JAN-2023, the patient received the 1st dose of Shingrix (intramuscular). On 25-JAN-2023, less than a day after receiving Shingrix, the patient experienced feeling sick (Verbatim: Feeling sick). The outcome of the feeling sick was resolved.   It was unknown if the reporter considered the feeling sick to be related to Shingrix.     It was unknown if the company considered the feeling sick to be related to Shingrix.   Linked case(s) involving the same patient:  US2023049150   Additional Information: GSK receipt date: 03-APR-2023 The reporter himself reported that he had his first dose of Shingrix on 25-Jan-2023 and afterwards he felt sick.  The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023049150:Same reporter
PATIENT FALSIFIED HER ADMINISTRATION FORM AND VACCINE INTERVIEW CLAIMING SHE HAD NEVER HAD THE COVID VACCINE BEFORE. UPON BATCH FILLING HOURS LATER, CMS REJECTED STATING SHE ALREADY RECEIVED THE J&J VACCINE. LOOKING AT SYSTEM, PATIENT RECEIVED VACCCINE IN MARCH 2021. WILL CONTACT MD MONDAY
Shortness of breath with progressive onset  Dyspnea with exertion or simple walking Emphysema/COPD (non smoking patient) Atelectasis   Other health issues since the vaccine that I didn?t have before: bacterial vaginosis, uti, random leg swelling
Initial misuse report received from a healthcare professional on 29 April 2013. A dose of ADACEL administered to patient, that had expired on 9/2/2012 was on 09 April 2013 (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
This was my second dose. About 1 minute  after vaccination Both sides of my mouth released saliva that tasted like copper.  My neck started swelling up like a bullfrog and I felt pressure on both sides of my throat and had difficulty swallowing. I was closely monitored in the clinic and treated with Pepcid and Zyrtec. The swelling receded. Within 10 minutes after medication and I went home. The coppery taste lingers.